Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Aug 10, 2017, after the close
10-Q filed Aug 10, 2017, 41 days after period end · 0000320017-17-000060
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Revenue | — | $8.30M | $5.87M | $4.49K |
| Net Income | $38.47M | -$7.88M | -$17.13K | -$12.61K |
| EPS Diluted |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| $4.34 |
| -$1.33 |
| -$3.84 |
| -$0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
